Evidence map›Paper›PMID 39035914›Full record

ArticleACS omega2024

Synthesis, Crystal Structure, Hirshfeld Surface Analysis, and Computational Approach of a New Pyrazolo[3,4-

Etify A Bakhite, Shaaban Kamel Mohamed, Chin-Hung Lai, Karthikeyan Subramani, Islam S Marae, Suzan Abuelhassan, Abdelhamid A E Soliman, Mohamed S K Youssef, Hatem A Abuelizz, Joel T Mague and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Etify A BakhiteDepartment of Chemistry, Faculty of Science, Assiut University, Assiut 71516, Egypt.ORCID https://orcid.org/0000-0003-3994-5629
Shaaban Kamel MohamedChemistry and Environmental Division, Manchester Metropolitan University, Manchester M1 5GD, England.
Chin-Hung LaiDepartment of Medical Applied Chemistry, Chung Shan Medical University, Taichung 40241, Taiwan.ORCID https://orcid.org/0000-0002-2768-7098
Karthikeyan SubramaniCenter for Healthcare Advancement, Innovation and Research, Vellore Institute of Technology University, Chennai Campus, Chennai 600127, India.
Islam S MaraeDepartment of Chemistry, Faculty of Science, Assiut University, Assiut 71516, Egypt.
Suzan AbuelhassanDepartment of Chemistry, Faculty of Science, Assiut University, Assiut 71516, Egypt.
Abdelhamid A E SolimanDepartment of Chemistry, Faculty of Science, Assiut University, Assiut 71516, Egypt.
Mohamed S K YoussefDepartment of Chemistry, Faculty of Science, Assiut University, Assiut 71516, Egypt.
Hatem A AbuelizzDepartment of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Joel T MagueDepartment of Chemistry, Tulane University, New Orleans, Louisiana 70118, United States.
Rashad Al-SalahiDepartment of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.ORCID https://orcid.org/0000-0003-1747-2736
Youness El BakriDepartment of Theoretical and Applied Chemistry, South Ural State University, Lenin prospect 76, Chelyabinsk 454080, Russian Federation.ORCID https://orcid.org/0000-0002-5759-6568

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ethyl-2-((8-cyano-3,5,9a-trimethyl-1-(4-oxo-4,5-dihydrothiazol-2-yl)-4-phenyl-3a,4,9,9a-tetrahydro-1

Identifiers

PMID39035914
PMCPMC11256088

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.